Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD

Plerixafor effectively mobilizes CD56^bright NK cells in blood, providing an allograft predicted to protect against GVHD

Blood. 2018 Jun 21;131(25):2863-2866. doi: 10.1182/blood-2018-03-836700. Epub 2018 May 4.

Peggy P C Wong^{1

2}, Amina Kariminia³, David Jones⁴, Connie J Eaves^{5

6

7}, Ronan Foley^{8

9}, Sabine Ivison³, Stephen Couban¹⁰, Kirk R Schultz^{1

2

3}

¹ Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, BC Children's Hospital, Vancouver, BC, Canada.
² Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
³ Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
⁴ Department of Medicine, Memorial University, St. Johns, NL, Canada.
⁵ Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
⁶ Department of Medicine and.
⁷ Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
⁸ Hamilton Health Sciences Centre, Hamilton, ON, Canada.
⁹ Department of Medicine, McMaster University, Hamilton, ON, Canada; and.
¹⁰ Department of Medicine, Dalhousie University, Halifax, NS, Canada.

No abstract available